Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627736 | 0.84 | — | — | |
| Bromide SCHEMBL6155997 | 0.81 | — | — | |
| Fluoride Ion SCHEMBL1961247 | 0.81 | — | — | |
| Nitrous Acid SCHEMBL7032211 | 0.80 | ALDH1A1 (0.32) | — | |
| Sulfuric Acid SCHEMBL7037387 | 0.78 | MEN1 (0.40) | MEN1KMT2A | |
| SCHEMBL5100196 | 0.72 | BCHE (0.33) | — | |
| Thiocyanic Acid SCHEMBL5096340 | 0.69 | — | — | |
| Nitromethane SCHEMBL3273015 | 0.67 | HTT (0.39) | KMT2ACA5ACA5B | |
| Methyl Alcohol SCHEMBL27918104 | 0.65 | MEN1 (0.60) | MEN1KMT2ACA5ACA5B | |
| SCHEMBL28208010 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030163000-A1 | Halogen exchange reactions and catalysts therefor | CHORDIP LTD. (GB) | 2003-08-28 | — | — | US | disclosed |
| EP-1288196-A1 | Process for the preparation of organo guanidinium salts | Chordip Ltd. (GB) | 2003-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030163000-A1 | Halogen exchange reactions and catalysts therefor | WEE2, WEE1, SLC39A11 | MEN1 3461/4885KMT2A 483/4885CA5A 3606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.